Neda Hamadani

Strategic partner and Chief of Staff to the VP of Immunology, helping build and scale a new business unit positioned as a significant future growth driver for Genentech. Brought onto the team during its formation to help establish the organizational infrastructure and operating capabilities required to launch and grow in new therapeutic areas and customer markets.

• Helped build the Immunology business from the ground up, establishing operating infrastructure, governance, organizational capabilities, and ways of working to support rapid growth.
• Drive strategic and operational readiness for one completed and two upcoming launches in under two years , supporting Genentech's expansion into new disease areas and customer segments.
• Partner with senior leadership on portfolio priorities, resource allocation, organizational design, and capabilities required to support two major growth areas.
• Play a key role in building Genentech's new GI commercial organization , partnering on organizational design, workforce sizing, leadership structure, and capabilities required for future launches.
• Help shape the evolving commercial leadership structure and operating model to enable the organization to scale with the portfolio.
• Drove alignment across Commercial, Medical, Access, Customer Engagement, and enterprise partners around critical priorities, decisions, and execution.

Strategic operations partner to the VP of Oncology, supporting an established, market-leading product navigating an increasingly competitive landscape.

• Partnered with senior leadership to shape business priorities and competitive strategy in response to a major emerging competitor.
• Drove strategic planning, prioritization, and execution to strengthen the product's competitive position and sustain long-term value.
• Developed business and value cases to inform investment, resource allocation, and organizational priorities.
• Led leadership-team operations and cross-functional alignment across Commercial, Medical, Access, and key enterprise partners.
• Led the operations team and established governance and operating rhythms to drive execution against critical business priorities.

Strategic business partner to scientific leadership across a portfolio of research through Phase I assets, connecting scientific strategy with business, investment, and organizational priorities.

• Partnered with scientific leaders to develop business cases supporting molecule advancement and development, integrating scientific rationale with strategic, financial, and resource considerations.
• Translated organizational objectives into actionable strategies and operating plans to advance research and early-development priorities.
• Guided portfolio planning, investment decisions, and resource allocation across early-stage programs.
• Led financial planning, budgeting, headcount and workforce planning to align resources with scientific and portfolio priorities.
• Provided business leadership across scientific teams, enabling researchers and development leaders to focus on advancing the science while ensuring strong operational and strategic execution.

Led global search and evaluation of external Oncology opportunities to identify potential partnerships and investments aligned with Genentech/Roche's global Oncology strategy.

• Evaluated 150+ external opportunities , assessing strategic fit against global portfolio priorities, investment areas, and unmet patient need.
• Proactively identified and pursued high-potential assets and technologies aligned with Oncology strategy and future portfolio needs.
• Partnered with senior scientific leaders to assess scientific rationale, clinical feasibility, differentiation, and development potential.
• Advanced promising opportunities from scientific assessment through business evaluation, integrating strategic, clinical, and commercial considerations.
• Served on cross-functional deal teams conducting deep-dive diligence to assess asset feasibility, investment potential, portfolio fit, and potential patient impact.

Business partner to scientific leadership supporting research and early development programs, translating scientific priorities into business plans, investment needs, and operational execution.

• Developed business cases and strategic plans that advanced early stage molecules and aligned with scientific priorities.
• Partnered with scientific leaders to translate research objectives into actionable business and operational plans.
• Managed financial planning, budgets, headcount, and resource allocation to optimize performance across scientific teams and programs.
• Supported portfolio planning and investment decisions by integrating scientific, financial, and organizational considerations.
• Drove cross-functional initiatives and operational improvements that enhanced execution of research and development goals.

Manager at Accenture with a focus on the Pharmaceutical and Biotechnology industry. I worked at nine separate pharmaceutical clients during my tenure at Accenture in addition to working with a non-profit consortium of 18 different biopharma companies.

Executed projects including capability assessments, growth strategy, product launch planning, operating model redesign, five-year strategic assessments, business cases, thought leader segmentation and strategy, and patient assistance program development. Collaborated across functional areas including medical affairs, clinical development, commercial, and marketing. Led projects Europe and Asia, expanding global perspective and understanding of diverse pharmaceutical markets.

Business Analyst and Clinical Research Associate (Phase III-Phase IV studies) for the global clinical solutions group. Managed global systems and business optimization across various functional groups within the vascular division of Abbott Laboratories.

Clinical Operations Associate for a leading pharmaceutical image analysis organization dedicated to global clinical trials.

Coordinated patient consent and tracking activities to ensure successful execution of breast clinical trials at UCSF Breast Cancer Center, encompassing Phase I-III surgery and oncology studies.

• Coordinated participant scheduling, visit logistics, and follow-up for complex clinical research protocols.
• Managed informed consent documentation and maintained protocol compliance with regulatory requirements.